Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Internet

Stock in News: Google (NASDAQ GOOG) Set To Buy Inmobi?

Google (NASDAQ GOOG) has been a stand out performing stock in the market for some time now. The search engine giants have been in the news recently, where speculations have been rampant about a potential takeover of Indian startup inmobi by Google. With the likes of Facebook and other big companies looking to enter the digital ad space, such a potential move would be a … Continue reading Stock in News: Google (NASDAQ GOOG) Set To Buy Inmobi?

Richard Atkins
Finance, Internet

Stock in News: Microsoft (NASDAQ MSFT) Windows 10 Set To Boost MSFT Stock

Microsoft (NASDAQ MSFT) have been a stand out stock in the past few months. While few analysts have been looking for a minor correction, most of the market is optimistic about the stock. This is also because of the fact that Microsoft is on the verge of launching Windows 10 Operating System which got a very positive feedback from its technical preview. There are a … Continue reading Stock in News: Microsoft (NASDAQ MSFT) Windows 10 Set To Boost MSFT Stock

Richard Atkins
Services Sector

Services Sector Most Active: J.C. Penney Company (NYSE:JCP), Sirius XM Holdings (NASDAQ:SIRI), McDonald’s Corporation (NYSE:MCD), Rite Aid (NYSE:RAD)

J.C. Penney Company, Inc. (NYSE:JCP) received a vote of confidence and a rare Wall Street upgrade on Tuesday. The Plano-based department store was labeled an “American comeback story” by Citigroup’s retail analyst Oliver Chen, who upgraded the retailer’s stock from “neutral” to “buy” on Tuesday. J.C. Penney Company, Inc. (NYSE:JCP) stock performance was 2.97% in last session and finished the day at $8.67. Traded volume … Continue reading Services Sector Most Active: J.C. Penney Company (NYSE:JCP), Sirius XM Holdings (NASDAQ:SIRI), McDonald’s Corporation (NYSE:MCD), Rite Aid (NYSE:RAD)

Richard Atkins
Finance, Mobile

Stock in News: What Apple (NASDAQ AAPL) Watch Price Means In Terms of Watch Sales

Apple (NASDAQ AAPL) introduced a new line of product on Monday. The Cupertino based technology company came up with the Apple Watch product which is the newest product in the wearable technology segment. Amid much speculation and expectancy, Apple showed the features and specifications of the product, along with the price range. Despite the let down in terms of features and specifications, Apple watch certainly … Continue reading Stock in News: What Apple (NASDAQ AAPL) Watch Price Means In Terms of Watch Sales

Richard Atkins
Finance, Internet

Apple (NASDAQ AAPL) Stock News: Looking At The Apple Watch Features

Apple (NASDAQ AAPL) officially unveiled its Apple Watch product on Monday in an event which showcased all the features of the much anticipated product. Apple have been quite upbeat about the product and the market had been eagerly waiting for the product. Many were expecting this product to change the landscape of the wearable technology industry. While a lot of features make this product a … Continue reading Apple (NASDAQ AAPL) Stock News: Looking At The Apple Watch Features

Richard Atkins
BioTech, Stock Movers

BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Myriad Genetics (NASDAQ:MYGN) is lower after the molecular diagnostic company disclosed in a regulatory filing Tuesday that the U.S. District Court for the District of Utah has denied the company’s motion for preliminary injunctive relief against Ambry Genetics’s sale of certain testing services that MYGN believes infringes on its patents. Shares are down 9.80% at $34.04, with a 52-week range of $20.02 – $39.15. Myriad … Continue reading BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Richard Atkins